News

Analysts Adjust Forecasts Ahead of Albertsons Earnings Release

Analysts Adjust Forecasts Ahead of Albertsons Earnings Release

Anticipated Earnings Call for Albertsons Companies

Albertsons Companies, Inc. (NYSE: ACI) is set to announce its financial performance for the third quarter soon, generating excitement among investors and analysts. The earnings report, which is expected to be released right before the market opens, will serve as a vital indicator of the company’s financial health.

Expected Earnings and Revenue Insights

The financial community forecasts that Albertsons will report earnings of 68 cents per share for the quarter. This is a slight decline from the previous year's figure, where the company earned 71 cents per share. Analysts also project an increase in revenue, expecting the company to generate about $19.17 billion, compared to $18.77 billion in the corresponding period last year.

Recent Financial Performance

Back in mid-October, Albertsons surprised many by reporting better-than-anticipated financial results for the second quarter. The company also provided an optimistic outlook by raising its earnings forecast for the fiscal year 2025. This upward revision has contributed positively to investor sentiment.

Stock Performance Analysis

On the trading front, Albertsons’ stock saw a minor decline of 0.5%, bringing its closing price to $17.17 recently. Such fluctuations in stock prices are common, especially as companies approach their earnings announcements, reflecting market sentiments and predictions.

Analyst Ratings and Forecast Adjustments

As the earnings call draws nearer, what do analysts have to say? Here are some insights from leading financial analysts regarding Albertsons:

  • Michael Montani from Evercore ISI Group retained an In-Line rating but adjusted the price target downward, reducing it from $21 to $20 as of late December.
  • Ivan Feinseth of Tigress Financial maintained a Buy rating while slightly increasing the price target from $28 to $29 in his recent analysis.
  • Analyst Mark Carden from UBS also maintained a Buy rating but lowered the price target from $27 to $25, reflecting cautious optimism.
  • At Wells Fargo, Edward Kelly upheld an Overweight rating yet reduced the price target from $27 to $23, indicating a cautious approach.
  • Finally, RBC Capital's Steven Shemesh kept an Outperform rating but adjusted the target price from $23 to $21.

Investment Considerations

If you’re contemplating investing in ACI stock, it’s essential to consider the perspectives of these analysts. Their adjustments indicate a mix of caution and positivity, providing a nuanced view of the company’s potential in the upcoming quarters.

Frequently Asked Questions

What is the expected earnings report date for Albertsons?

Albertsons is expected to release its earnings report for the third quarter before the market opens on Wednesday.

What are the projected earnings per share for Albertsons?

The anticipated earnings per share for Albertsons is 68 cents, signaling a fall from last year's 71 cents.

How have analysts rated Albertsons recently?

Analysts rate Albertsons with a mix of recommendations, including Buy and In-Line ratings, with adjusted price targets reflecting varying market sentiments.

What was Albertsons' recent stock performance?

Albertsons’ stock recently closed at $17.17, down marginally by 0.5% as traders prepare for the forthcoming earnings call.

Are there any major shifts in revenue forecast?

Yes, revenue is projected at $19.17 billion for the quarter, indicating a growth from the previous year's $18.77 billion.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 18

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 30

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 26

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 29

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 17

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 28

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 25

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

MarketWise's Strategic Position: Navigating Challenges Ahead

Updated Category News Views 123

MarketWise, Inc. (NASDAQ:MKTW) faced a rocky road since its SPAC merger back in July 2021. After initial pandemic-fueled growth due to retail investors diving into the market, the winds changed. Now, MarketWise's struggling under a mix of management shakeups and an unforgiving economic environment. Understanding MarketWise's Value Proposition The company's core business...

Continue Reading
NTT Emphasizes AI Cloud Development at R&D Forum 2024

Updated Category News Views 219

NTT's Commitment to Industry-Specific AI Solutions NTT Corporation hosted a groundbreaking forum in Tokyo to highlight its commitment to innovative solutions. This year’s R&D Forum showcased NTT's dedication to creating a sustainable society through the effective use of AI technology. During the event, NTT President and CEO Akira Shimada discussed the Innovative Optical...

Continue Reading
Oculis Enhances Financial Flexibility with Expanded Loan Facility

Updated Category News Views 146

Oculis Enhances Financial Flexibility with Expanded Loan Facility Oculis Holding AG (Nasdaq: OCS; Iceland: OCS) has made a strategic move to bolster its financial resources. The biopharmaceutical company, dedicated to addressing critical unmet medical needs in ophthalmology and neuro-ophthalmology, revealed they have entered into an amended loan agreement with BlackRock....

Continue Reading
Abbott's New Glucose Monitor: A Game Changer for Consumers

Updated Category News Views 85

Abbott Launches Innovative Glucose Monitoring Solution Abbott has recently made a significant impact in the health technology field with the introduction of its eagerly awaited over-the-counter continuous glucose monitoring system called Lingo, now available in the United States. This state-of-the-art device is specifically designed for consumers aged 18 and older who do...

Continue Reading
Longshot Partners with Mettle Ops in SHIELD Contract Win

Updated Category News Views 154

Longshot and Mettle Ops Join Forces in a Major Contract Longshot, a prominent defense and space technology firm, has joined the Mettle Ops team to secure a position on the Missile Defense Agency's (MDA) prestigious Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) Indefinite Delivery/Indefinite Quantity (IDIQ) contract. This contract opens exciting...

Continue Reading